Company Biotage AB

Equities

BIOT

SE0000454746

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Ratings for Biotage AB

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Diagnostic & Testing Equipment

Market Closed - Nasdaq Stockholm Other stock markets 11:29:55 2024-04-23 am EDT			5-day change	1st Jan Change
162.9 ^SEK	+1.81%		-4.35%	+21.84%

Feb. 16	Nordic Stocks Closed Up Friday; Yubico Led Increases	DJ
Feb. 15	Nordic Shares Rose Thursday; Tomra Systems Climbed Highest	DJ

Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The Company offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotageâs offering within analytical chemistry consists of consumables with related applications to extract selected substances from various types of samples. The Companyâs offering within organic chemistry includes products for pharmaceutical development based on both small molecules and peptides and its offering within industrial resins is composed of polymer-based resins and research services that lead to the development and manufacture of polymer-based materials. As of December 31, 2013, the Company operated 12 wholly owned subsidiaries worldwide.

Number of employees: 674

SEK in Million	2022	Weight	2023	Weight	Delta
Small Molecules & Synthetic Therapeutics 35.1 %	770	49.1 %	654	35.1 %	-15.06%
Biologics & Advanced Therapeutics 24.4 %	66	4.2 %	454	24.4 %	+587.88%
Analytical Testing 22.3 %	382	24.4 %	415	22.3 %	+8.64%
Scale-up 8.2 %	181	11.6 %	152	8.2 %	-16.02%
Water & Environmental Testing 7.1 %	122	7.8 %	133	7.1 %	+9.02%
Diagnostics 2.9 %	46	2.9 %	54	2.9 %	+17.39%

SEK in Million	2022	Weight	2023	Weight	Delta
North and South America 40.2 %	660	42.1 %	748	40.2 %	+13.33%
EMEA 39.2 %	376	24.0 %	729	39.2 %	+93.88%
China 7.5 %	232	14.8 %	139	7.5 %	-40.09%
Japan 6.0 %	115	7.3 %	111	6.0 %	-3.48%
South Korea 3.2 %	61	3.9 %	60	3.2 %	-1.64%
Other APAC 1.8 %	-	-	33	1.8 %	-
India 1.5 %	32	2.0 %	27	1.5 %	-15.62%
Sweden 0.8 %	18	1.1 %	15	0.8 %	-16.67%

Managers	Title	Age	Since
Torben Vedel Stahl Jörgensen CEO	Chief Executive Officer	72	06-02-08
Andrew Kellett DFI	Director of Finance/CFO	56	23-09-24
Maryam Poorafshar CTO	Chief Tech/Sci/R&D Officer	54	-
Magnus Nordstedt CTO	Chief Tech/Sci/R&D Officer	54	01-12-31
Anders Wikström COO	Chief Operating Officer	51	02-09-30
Lisa Egelrud LAW	General Counsel	49	-
Raffaella Bombarda SAM	Sales & Marketing	50	-
Olof Nord PRN	Corporate Officer/Principal	49	-
Petra Duprez HRO	Human Resources Officer	59	20-04-30

Members of the board	Title	Age	Since
Torben Vedel Stahl Jörgensen CEO	Chief Executive Officer	72	06-02-08
Åsa Hedin BRD	Director/Board Member	62	19-10-31
Kieran Murphy CHM	Chairman	61	Jan. 03
Peter von Ehrenheim BRD	Director/Board Member	69	-
Mark Bradley BRD	Director/Board Member	62	19-04-23
Karen Sørensen BRD	Director/Board Member	62	-
Daniel Menasco BRD	Director/Board Member	47	14-12-31
Pär Lundgren BRD	Director/Board Member	39	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	80,008,185	79,645,985 ( 99.55 %)	0	99.55 %

Name	Equities	%	Valuation
Gamma Biosciences Newco Ltd. 14.93 %	11,946,867	14.93 %	203 M kr
Didner & Gerge Fonder AB 6.690 %	5,352,907	6.690 %	91 M kr
Invesco Advisers, Inc. 4.760 %	3,808,712	4.760 %	65 M kr
Handelsbanken Fonder AB 4.250 %	3,400,219	4.250 %	58 M kr
Fjärde AP-fonden 3.357 %	2,685,540	3.357 %	46 M kr
Swedbank Robur Fonder AB 3.304 %	2,643,470	3.304 %	45 M kr
Tredje AP-fonden 2.194 %	1,755,168	2.194 %	30 M kr
Gamma Biosciences Newco 2 Ltd. 2.055 %	1,643,781	2.055 %	28 M kr
Första AP-fonden 1.955 %	1,563,815	1.955 %	27 M kr
Teknik Innovation Norden Fonder AB 1.227 %	981,609	1.227 %	17 M kr

Biotage AB

Vimpelgatan 5

753 18, Uppsala

+46 18 56 59 00

http://www.biotage.com

Name	Category and Sector
Biotage Sweden AB Biotage Sweden AB Medical SpecialtiesHealth Technology Part of Biotage AB, Biotage Sweden AB is a Swedish impact tech company committed to solving society ’ s problems. The private company is based in Uppsala, Sweden. The company offers solutions in drug discovery, analytical, water, and environmental testing. Biotage provides workflow solutions and products to customers in drug discovery and development, analytical testing, and water and environmental testing. The company was founded in 1989 by Sheridan G. Snyder.	Medical Specialties

Name

Category and Sector

Medical Specialties

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

162.9 SEK

Average target price

186.7 SEK

Spread / Average Target

+14.59%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
BIOTAGE AB	+21.84%	1.17B
QUIDELORTHO CORPORATION	-45.18%	2.61B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+15.62%	1.76B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-2.14%	1.51B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-13.27%	943M
CONTEC MEDICAL SYSTEMS CO.,LTD	-21.67%	883M
REVENIO GROUP OYJ	-6.04%	701M
VAREX IMAGING CORPORATION	-15.76%	693M
CELLAVISION AB	+12.74%	509M
PHC CO.,LTD.	-.--%	301M

Medical Diagnostic & Testing Equipment